Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer

ClinicalTrials.gov ID: NCT03646162

Public ClinicalTrials.gov record NCT03646162. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind, Placebo Controlled, Dose Finding Phase 2 Study Comparing Oral Daily Dosing of VERU-944 to Ameliorate the Vasomotor Symptoms Resulting From ADT in Men With Advanced Prostate Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Randomized, double-blind, placebo controlled, dose finding Phase 2 study comparing oral daily dosing of VERU-944 after a week of loading (daily dosing) with placebo to ameliorate the vasomotor symptoms resulting from androgen deprivation therapy in men with advanced prostate cancer

Study identification

NCT ID
NCT03646162
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Veru Inc.
Industry
Enrollment
93 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2018 (Actual)
Primary completion
Apr 30, 2020 (Actual)
Completion
Oct 15, 2020 (Actual)
Last update posted
Dec 3, 2021

2018 – 2020

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Gen1 Research Glendale Arizona 85308 —
Tower Urology Los Angeles California 90048 —
Urology of San Bernardino San Bernardino California 92404 —
The Urology Center of Colorado Denver Colorado 80211 —
Foothills Urology Golden Colorado 80401 —
Universal Axon Clinical Research Doral Florida 33166 —
Medical Research Center Miami Florida 33144 —
North Idaho Urology Coeur d'Alene Idaho 83814 —
First Urology Jeffersonville Indiana 47130 —
Regional Urology LLC Shreveport Louisiana 71101 —
Chesapeake Urology Towson Maryland 21204 —
Coastal Urology Brick New Jersey 08724 —
Premier Urology Group Edison New Jersey 08837 —
Advance Urology Elmont New York 11003 —
AccuMed Research Garden City New York 11530 —
Premier Medical Group of the Hudson Valley Poughkeepsie New York 12601 —
Associated Medical Professionals Syracuse New York 13210 —
Clinical Research Solutions Middleburg Heights Ohio 44130 —
Urologic Consultants Bala-Cynwyd Pennsylvania 19004 —
Mary Crowley Cancer Research Dallas Texas 75230 —
Urology Clinics of North Texas Dallas Texas 75231 —
Houston Urology Partners Houston Texas 77091 —
Urology San Antonio San Antonio Texas 78229 —
Urology of Virginia Virginia Beach Virginia 23462 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03646162, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2021 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03646162 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →